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Depression and anxiety disorders are characterized by complex and idiopathic etiologies. One
prominent hypothesis, termed “the neurogenesis hypothesis,” posits that stress-induced decreases
in hippocampal neurogenesis underlie depressive episodes (Jacobs et al., 2000). Glucocorticoids are
primary effectors of the stress response. Acute glucocorticoid exposure enhances cognitive capacity
by altering hippocampal synaptic plasticity. In contrast, chronic exposure causes hippocampal
atrophy via excessive glutamate, calcium, and oxygen free radical generation. The hippocampus
has become central in affective disorder research because blocking hippocampal neurogenesis
eliminates some beneficial effects of monoaminergic antidepressants (Surget et al., 2008), whereas
increasing neurogenesis reduces glucocorticoid-induced anxiety- and depressive-like responses
(Hill et al., 2015).
In contrast, the behavioral consequences of neurogenesis in the olfactory bulb (OB), the other
brain structure that integrates new neurons in the adult mammalian brain, remains unspecified.
Subventricular zone (SVZ) neuroblasts migrate to the OB along the rostral migratory stream
(RMS). Chronic stress affects this migration (e.g., Yang et al., 2011). Olfactory neurogenesis occurs
in humans (Curtis et al., 2007); patients with major depression display impaired olfactory function
and sensitivity; it is unknown whether these changes are related to glucocorticoid dysregulation
and reduced neurogenesis that often accompanies depressive disorders.
A new study Siopi et al. (2016) provides evidence that chronic corticosterone exposure
decreases OB cell survival leading to impaired olfactory function. A subset of the observed
deficits could be rescued by co-administration of fluoxetine (FLX), a commonly prescribed
selective serotonin reuptake inhibitor (SSRI). Specifically, mice administered corticosterone
decreased olfactory discrimination, acuity, and memory. FLX in combination with corticosterone
restored deficits in olfactory acuity and memory, but not olfactory discrimination. FLX alone
impaired these same measures. Together, these data imply that FLX rescues corticosterone-
induced deficits, but has a paradoxically detrimental effect when administered in the absence
of elevated glucocorticoids. Notably, chronic corticosterone treatment did not impair cell
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proliferation (Ki67+ cells) within the olfactory epithelium or OB
sensory afferentation (OMP+ cells), suggesting deficits in odor
processing rather than detection. Corticosterone administration
decreased cell proliferation in the dentate gyrus (DG), but did
not affect cell proliferation in the SVZ. These data suggest a
different mechanism by which corticosterone affects neuroblasts
destined for the OB. To investigate this, survival of newly
born neurons maturing in the DG and OB was examined.
Glucocorticoids decreased cell survival in both regions; this
effect was prevented by co-administration of FLX. Additionally,
dendritic complexity of newly integrated neurons increased
following FLX administration, potentially contributing to the
partially rescued phenotype. Taken together, these results link
major depressive disorder and neurogenesis-dependent olfactory
deficits within the DG and OB. Understanding the implications
of impaired olfactory function and neurogenesis in depressed
humans warrants further investigation; additional mechanisms
by which glucocorticoids modulate neurogenesis and functional
synapse formation should be examined.
The translational significance of these new data is worth
considering in the context of vast species differences in rates
of olfactory neurogenesis and reliance on olfaction. Rodents
rely more heavily on olfaction than humans, and neurogenic
rates in the OB are minimal in adult humans (Kam et al.,
2009). However, at the anatomical level, there are similarities
in neurogenesis across species. Analysis of OBs from patients
treated with 5-bromo-2′-deoxyuridine (BrdU) reveal that human
progenitor cells from the SVZ also travel through the RMS to
the OB where they mature (Curtis et al., 2007). The functional
implications of olfactory neurogenesis in depression and anxiety
disorders remain understudied; converging evidence suggests
that impaired olfactory function predicts disease progression
FIGURE 1 | Effect of CORT and FLX treatment on adult mouse neurogenesis. CORT treatment decreases cell proliferation and survival in the SGZ, ultimately
associated with increased depressive- and anxiety-like behaviors. However, CORT has no effect on SVZ neurogenesis. Neuroblasts travel from the SVZ along the
RMS to the OB. CORT treatment decreases neuroblast survival and dendritic complexity in the OB, leading to overall decreased olfactory function. FLX, when
co-administered with CORT, restores cell survival and olfactory function. CORT, corticosterone; FLX, fluoxetine; SGZ, subgranular zone; SVZ, subventricular zone;
RMS, rostral migratory stream; OB, olfactory bulb; LV, lateral ventricle.
(e.g., Roberts et al., 2016). For example, untreated suicide
victims accumulated neural progenitor cells (Doublecortin+)
in the SVZ and OB relative to psychiatrically healthy people
(Maheu et al., 2015). In antidepressant-treated suicide victims,
the number of Doublecortin+ cells in the SVZ was reduced
without simultaneous reductions in the OB. These data suggest
that impaired migration and ectopic differentiation leads to
neuroblast accumulation in the OB of unmedicated depressed
individuals. Antidepressant treatment facilitates neuroblast
migration out of the SVZ, but cells that differentiated ectopically
prior to treatment persist (Maheu et al., 2015). Contrary
to the migration and differentiation impairment hypothesis
(Maheu et al., 2015), reduced cell survival underlies rodent
deficits in olfactory neurogenesis (Siopi et al., 2016). The
differences between clinical and mouse data warrant further
studies of depression-induced deficits in olfactory neurogenesis
and function.
Although stress-induced increases in glucocorticoids directly
regulate neurogenesis, immune cells are also responsible for
maintenance of the neurogenic niche (Ziv et al., 2006) and
may provide an indirect mechanism through which stress
alters neurogenesis. Specifically, microglia are responsible for
clearance of apoptotic neuroprogenitors and neuroblasts and are
highly responsive to glucocorticoids. Chronic exposure activates
microglia and induces a pro-inflammatory phenotype (Nair and
Bonneau, 2006) that is ultimately detrimental to neurogenesis
(Battista et al., 2006); OB microglia may play a role in regulating
neurogenesis in a minimally activated state (Lazarini et al.,
2012). Therefore, microglial activation may contribute to the
phenotype observed (Siopi et al., 2016). FLX reverses deficits
in cell proliferation and survival both in the DG and OB.
Serotonin increases cell proliferation and neurogenesis, acting
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on microglia to reduce phagocytic activity (Krabbe et al., 2012).
Thus, decreased cell clearance may account for increased cell
survival in mice receiving a combination of corticosterone and
FLX (Siopi et al., 2016). Along with increased survival, new
neurons in the OB of FLX + corticosterone- and FLX-treated
animals increased dendritic length and branching. Synaptic
pruning is also regulated by microglia. Examining whether these
dendrites are forming functional synapses could provide insight
into why FLX-treated animals did not improve in olfactory
tests.
In sum, Siopi and colleagues suggest that chronic elevated
glucocorticoids reduce hippocampal and olfactory neurogenesis,
leading to depressive-like states and impaired olfactory
function (Figure 1). Fluoxetine restores hippocampal
neurogenesis and cell survival of newly born neurons
integrating into the olfactory bulb. We advocate for further
studies on the functional significance of human olfactory
neurogenesis in depressed patients. Additionally, glial
contributions to neurogenesis and synapse formation should
be considered in the context of depression and olfactory
function.
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